Panna Sharma has significant public and private experience in leading biotech, high-tech and emerging technology companies grow through a combination of organic mechanisms, internal alignment, capital-raising and strategic transactions. He is heavily focused on oncology, drug development, and the use of AI and machine learning to change the risk, cost and timeline in the highly interdisciplinary field of personalized medicine.